Publications by authors named "Stephan Torres-Jorge"
Vaccines (Basel)
August 2022
Article Synopsis
- - The study assesses the humoral response to SARS-CoV-2 variants in inflammatory bowel disease (IBD) patients 60 days after receiving a third vaccine dose (Pfizer-BioNTech or Moderna), given concerns about vaccine effectiveness due to immunosuppression treatments.
- - Out of 56 IBD subjects, 24 individuals failed to achieve effective neutralizing capability against the Omicron variant, and 70% of these individuals were on anti-tumor necrosis factor therapies, with some showing no neutralization ability against other variants as well.
- - In contrast, all healthy control subjects developed detectable antibodies and effective neutralization against all seven variants tested, indicating that IBD patients may have inadequate protection against COVID
